Akèy › Metiyè › Natural Sciences Managers › Durham, NC
Natural Sciences Managers nan Durham, NC: Salè H-1B
30 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Durham, NC. Salè baz medyàn ofri $121,524; mwatye mitan $96,367–$133,389.
Demann (LCA)30
Salè medyan ofri$121,524
Mwatye salè yo$96,367–$133,389
10yèm–90yèm pousantaj$75,665–$169,500
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $126,812 |
| Nivo II (kalifye) | $114,064 |
| Nivo III (eksperyans) | $103,052 |
| Nivo IV (plen kompetans) | $213,886 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Duke University | 17 | $100,000 |
| NeoGenomics Laboratories, Inc. | 3 | $125,623 |
| KBI Biopharma, Inc. | 2 | $177,500 |
| Tergus Pharma, LLC | 1 | $130,000 |
| Precision BioSciences, Inc. | 1 | $128,000 |
| Biogen Inc. | 1 | $144,102 |
| IQVIA RDS Inc. | 1 | $103,010 |
| Fortrea Inc. | 1 | $213,886 |
| MedPharm Manufacturing Services LLC | 1 | $142,744 |
| Fortrea Inc. f/k/a LabCorp Drug Development Inc. | 1 | $165,000 |
| Lexeo Therapeutics, Inc. | 1 | $180,000 |
Tit travay
- Research Program Leader5
- Associate Director2
- Assistant Director2
- Associate Research Laboratory Manager2
- Project Coordinator2
- Associate Laboratory Director2
- Supervisor/Senior Scientist, CMC - Analytical Development1
- Assist Director1
- Natural Science Manager1
- Research Program Lead1
- Associate Director, MS&T1
- Principal Programmer, TC&S, SDTM Operations1
- Clinical Research Associate 21
- Research Program Leader Sr.1
- Senior Policy Associate1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).